Antiviral Activity of Glycyrrhetinic Acid on MA-104 Cell Infection of the K-21 Korea Human Rotavirus Isolate

참고문헌 (Reference)

1 박범석, "키토올리고당과 수용성 키토산의 열처리가 올리고당 함량의 변화와 항 로타바이러스성에 미치는 영향" 한국동물자원과학회 44 (44): 809-816, 2002

2 Centers for Disease Control and Prevention (CDC), "Withdrawal of rotavirus vaccine recommendation" MMWR Morb Mortal Wkly Rep. 1999

3 RF,Bishop, "Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis" Lancet 1281-1283, 1973

4 U,Desselberger, "The rotavirus genome" 185 : 31-55, 1994

5 CH,Kee, "The pharmacology of chinese herbs" CRC Press, Inc. 275-, 1993

6 RE,Linhares, "The in vitro antiviral activity of isoprinosine on simian rotavirus (SA-11)" 22 : 1095-1103, 1989

7 HF,Clark, "The development of a multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants" 174 : 73-80, 1996

8 S,Harada, "The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope" 392 : 191-199, 2005

9 RS,Finney, "The anti-inflammatory activity of glycyrrhetinicacid and derivatives" 10 : 613-620, 1958

10 TH,Flewett, "The Rotavirus" 57 : 1-23, 1978

11 M,Koketsu, "Sialyloligosaccharides of egg yolk fraction" 58 : 743-747, 1993

12 M,Koketsu, "Sialyloligosaccharides from egg yolk as an inhibitor of rotaviral infection" 43 : 858-861, 1995

13 RH,Yolken, "Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses" 79 : 148-154, 1987

14 AZ,Kapikian, "Rotaviruses: Virology 2, 2nd" Raven press 1404-1656, 1990

15 AZ,Kapikian, "Rotaviruses Fields virology 4th" Williams & Wilkins. Philadelphia. 1787-1833, 2001

16 MK,Estes, "Rotavirus; A review" 105 : 123-184, 1983

17 ME,Conner, "Rotavirus vaccines and vaccination potentional" 185 : 285-337, 1994

18 MK,Estes, "Rotavirus gene structure and function" 53 : 410-449, 1989

19 T,Ebina, "Protease inhibitors prevent the development of human rotavirus-induced diarrhea in suckling mice" 35 : 583-588, 1991

20 OM,Perez, "Prevalence of antibodies to hepatitis A, B, C and E viruses in a healthy population in Leon, Nicaragua" 55 : 17-21, 1996

21 T,Hattori, "Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS" 11 : 255-261, 1989

22 MA,Miller, "Policy analysis of the use of hepatitus B, Haemophilus influenzae type b-, Streptococcus pneumoniaeconjugate and rotavirus vaccines in national immunization schedules" 9 : 19-35, 2000

23 MM,Azimov, "Pharmacological study of the anti - inflammatory agent glyderinine" 51 : 90-93, 1988

24 H,Yamamoto, "Localization of prenylated flavonoids Insophora flavescens var" Z.Naturforsch 47 : 535-539, 1992

25 PS,Paul, "Isolation of bovine rotavirus with a super-short RNA electropherotic pattern from a calf with diarrhea" 26 : 2139-2143, 1988

26 H,Hasegawa, "Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antiviral activities" 60 : 240-243, 1994

27 DF,Smee, "Inhibition of rotaviruses by selected antiviral substances: mechanisms of antiviral inhibition and in vivo activity" 21 : 66-73, 1982

28 KT,Kaljot, "Infectious rotavirus enter cells direct cell membrane penetration, not by endocytosis" 62 : 1136-1144, 1988

29 SF,Berkley, "Infectious Diseases" Mosby. London. 1999

30 KH,Kim, "Importance of rotavirus and adenovirus type 41 and 41 acute gastroenteritis in Korea Children" 28 : 2279-2284, 1990

31 AZ,Kapikian, "Human reovirus-like agent as the major pathogen associated with winter gastroenteritis in hospitalized infants and young children" 294 : 965-972, 1976

32 RH,Yolken, "Human milk mucin inhibits rotavirus replication and prevents experimental gastroenteritis" 90 : 1984-1991, 1992

33 Y,Lange, "How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids" 101 : 2004

34 T,Tani, "Histochemistry VIII. Distribution of starch and isoflavones in Puerarise R Radix" 40 : 247-251, 1986

35 TGJ,Van Rossum, "Glycyrrhizin as a potential treatment for chronic hepatitis C" 12 : 199-205, 1998

36 R,Pompei, "Glycyrrhizic acid inhibits virus growth and inactivates virus particles" 281 : 269-690, 1979

37 JH,Musser, "Glycomimentics: an approach to discovering leads for therapeutics" 5 : 11-17, 1995

38 M,Lynch, "Gentsch and Roger I. Glass.Rotavirus vaccines" 13 : 495-502, 2000

39 H,Hayashi, "Formation of soyasaponins in licorice cell suspension cultures" 3127-3129, 1990

40 A,Kumagai, "Effects of glycyrrhizin on thymolytic and immunosuppressive action of cortisone" 14 : 39-42, 1967

41 K,Mori, "Effects of glycyrrhizin in hemo - philiapatients with HIV-1 infection" 162 : 183-193, 1990

42 JU,Song, "Effects of GA on a Korean bovine rotavirus infection" 89-, 1999

43 KJ,Cha, "Effect of bovine and human lactoferrin on MA 104 cell infected with human rotavirus" J.Korean Soc Virol. 87-97, 1999

44 JS,Bresee, "Current status and future priorities for rotavirus vaccine development, evaluation, and implementation in developing counties" Vaccine 2207-2222, 1999

45 S,Kitaoka, "Comparative efficacy of broadspectrum antiviral agents as inhibitors of rotavirus replication in vitro" 6 : 57-65, 1986

46 S,Kliewer, "Cholesterol detoxification by the nuclear pregnane X receptor" 102 : 2675-2676, 2005

47 Shin, DH, "Antimicrobial effect of ethanol extracts of Sinomenium acutum(Thunb.) Rehd.Glandulifera regal et Zucc on Listeria monocytogenes" 26 : 627-632, 1994

48 FM,Ruggeri, "Antibodies to the trypsin cleavage peptide Vp8 neutralize rotavirus by inhibiting binding of virions to target cells in culture" 65 : 2211-2219, 1991

49 TK,Lee, "Anti-HIV-1 viral activity of glycyrrhizin" 1 : 209-236, 1992

50 MK,Estes, "Advances in molecular biology:impact on rotavirus vaccine development" 174 : 37-46, 1996